HPV Vaccination in Populations with High HIV Prevalence

Three-page news brief by Cervical Cancer Action provides guidance on use of HPV vaccine in areas with high HIV prevalence. Key messages include:

 

• HPV infection doubles the risk of acquiring HIV in women and men. HIV also significantly increases the risk of persistent HPV infections, which can lead to cervical cancer.
• Studies show that HIV-infected women have the ability to mount the necessary immune response to HPV antigens—that is, they have the biological capacity to benefit from the vaccine.
• The potential benefit of the vaccine may be great due to this group’s increased risk for HPV-related disease.

Read in more detail here